ObsEva's EDELWEISS Trial Hits All Goals In Endometriosis-associated Pain

ObsEva SA's (OBSV) phase 2b clinical trial of Linzagolix for the treatment of endometriosis-associated pain has achieved primary and secondary endpoints.

from RTT - Biotech https://ift.tt/2yrjd86
via IFTTT